Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Freya Meds vs KERNX Health

Freya Meds
Graded #364

Lower grade

vs+3.299999999999997
KERNX Health
Graded #282

Higher grade

The verdict

KERNX Health takes it — 61.9/100 to 58.6/100.

KERNX Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKERNX Health +18
43
61
Dose & formulationEven
64
64
Clinical oversightEven
71
71
Labs & monitoringFreya Meds +8
60
52
FulfillmentKERNX Health +7
62
69
Contract termsFreya Meds +10
55
45
Freya Meds · left barKERNX Health · right bar

The numbers

MetricFreya MedsKERNX Health
WeighScore58.6/10061.9/100
GradeCC
Scorecard rank#364#282
Semaglutide$297/mo (compounded)$129/mo (promotional rate, plus a separate fee, compounded)
Tirzepatide$390/mo (compounded)$199/mo (promotional rate, plus a separate fee, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Freya Meds

Graded #364 · C

Strengths

  • GLP-1 specialist — not a multi-category telehealth
  • Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
  • Both semaglutide and tirzepatide available
  • Multi-month discount on quarterly billing
  • Claims 450,000+ enrolled

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Above-average pricing ($250–$390/mo)
  • Compounded only — no brand-name options
  • Now serves 49 U.S. states (one state excluded; specific exclusion not named)
KERNX Health

Graded #282 · C

Strengths

  • Publishes plan pricing openly, before any intake or account creation
  • Month-to-month with no long-term contract and no multi-month prepayment
  • Billing starts only after a licensed provider approves treatment
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
  • The consultation fee is charged whether or not a prescription is issued
  • Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
  • No compounding pharmacy is named anywhere on the site
  • Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard